Results 41 to 50 of about 643 (132)

Hodgkin Lymphoma Treatment With Brentuximab Vedotin in a Patient With HIV, Liver Failure, and Anemia Without Transfusion

eJHaem, Volume 6, Issue 1, February 2025.
ABSTRACT Brentuximab vedotin (BV) is a drug that has improved outcomes in classical Hodgkin lymphoma (cHL). However, its safety and efficacy in patients living with HIV who present with severe liver failure and life‐threating cytopenias is unclear. Here, we describe the case of a woman living with HIV diagnosed with cHL and how she recovered from a ...
Ellen Marin, Aseala Abousaud, Kathleen Davis, Bradley Sumrall, Shiyong Li, Amelia A. Langston, Andres Chang   +6 more
wiley   +1 more source

HIV Glasgow, 23–26 October 2022, Glasgow, UK / Virtual

, 2022
Journal of the International AIDS Society, Volume 25, Issue S6, October 2022.
wiley   +1 more source

Vergleichsanalyse des Therapieerfolgs bei HIV-Infizierten [PDF]

, 2019
Die Anzahl an mit dem HI-Virus Neuinfizierten sinkt aufgrund der stetig voranschreitenden Forschung im Bereich der Therapie der HIV-Infektion kontinuierlich.
Kaczmarek-Sondej, Wiktoria
core   +1 more source

Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System

Pharmacology Research &Perspectives, Volume 13, Issue 1, February 2025.
ABSTRACT The increasing utilization of cannabis products combined with lack of data regarding potential cannabis–prescription drug interactions is concerning. This study aimed to review published case reports and FDA Adverse Event Reporting System (FAERS) spontaneous reports to assess cannabis–drug interactions in persons aged 18 and over. A literature
Maryann R. Chapin, Sandra L. Kane‐Gill, Xiaotong Li, Kojo Abanyie, Sanya B. Taneja, Susan Egbert, Mary F. Paine, Richard D. Boyce   +7 more
wiley   +1 more source

DIAGNOSTIC CHALLENGES AND OUTCOMES OF EMPIRICAL THERAPY FOR NEUROCYSTICERCOSIS IN AN UNTREATED HIV PATIENT

Problems of Infectious and Parasitic Diseases
This case report describes a 35-year-old woman, Jane Doe (JD), who recently immigrated to Miami, Florida from Latin America and presented to the emergency department after a witnessed seizure.
Tomilya Simmons, Anastasia Amundson, Luke Myers, Lorena Del Pilar Bonilla   +3 more
doaj   +1 more source

Bictegravir/emtricitabine/tenofovir alafenamide in adults with HIV‐1 and end‐stage kidney disease on chronic haemodialysis

HIV Medicine, Volume 26, Issue 2, Page 302-307, February 2025.
Abstract Introduction Treatment for people with HIV‐1 and end‐stage kidney disease (ESKD) on haemodialysis (HD) has previously required complex dose‐adjusted regimens, with limited data on the use of a single‐tablet regimen in this population. Our aim was to assess the efficacy and safety of once‐daily bictegravir/emtricitabine/tenofovir alafenamide (B/
Joseph J. Eron, Moti Ramgopal, Olayemi Osiyemi, Mehri Mckellar, Jihad Slim, Edwin DeJesus, Priyanka Arora, Christiana Blair, Jason T. Hindman, Aimee Wilkin   +9 more
wiley   +1 more source

Pneumococcal Pyopericardium With Xiphoid Osteomyelitis in HIV/AIDS: A Rare but Potentially Fatal Complication

Case Reports in Cardiology, Volume 2025, Issue 1, 2025.
Background: Purulent pericarditis is a rare, life‐threatening condition that has become exceedingly uncommon due to widespread use of antibiotics. However, immunocompromised patients remain susceptible to such opportunistic infections. It is typically caused by direct extension or hematogenous spread from a secondary bacterial source. Case Description:
Nihar Jena, Izza Saeed, Mackenzie Hamilton, Christian Tocquica, Sreekant Avula, Ramiz Sayyed, Juan Bastidas, Mark Studeny, Kathleen Ngu   +8 more
wiley   +1 more source

Lytic reactivation of EBV by HIV proteins and antiretroviral therapy with the heightened expression of MEF-2 oncogenes implicated in AIDS-related cancer

The Microbe
Despite effective antiretroviral therapy (ART), people living with HIV (PLWH) remain at a higher risk of developing AIDS-related cancers. The factors attributed to this increased risk are multifactorial, including long-term ART use, prolonged exposure to
Alesha Philip, Thomas A. Premeaux, Adhikarimayum Lakhikumar Sharma, Cabirou Mounchili Shintouo, Aykan Karabudak, Liudi Tang, Salwa Ahmed, Alekhya Rani Chunduri, Sai Chaitanya R. Gaekwar, Elias Haddad, Ryan Hoffmann, Mudit Tyagi, Pooja Jain   +12 more
doaj   +1 more source

The Antiretroviral Pregnancy Registry: Three decades of prospective monitoring for birth defects

Pharmacoepidemiology and Drug Safety, Volume 33, Issue 6, June 2024.
Abstract Purpose Antiretrovirals (ARVs) are life‐saving drugs used for the treatment and prevention of HIV infection and antiviral drugs (AVs) for the treatment of chronic HBV infection. ARVs have proven highly effective in reducing perinatal HIV transmission, however the risk of birth defects from prenatal exposure to ARVs/AVs is an ongoing concern ...
Jessica D. Albano, Angela E. Scheuerle, D. Heather Watts, Karen P. Beckerman, Lynne M. Mofenson, Andreas Pikis, Vani Vannappagari, Daniel Seekins, Taylor S. Cook, Hugh Tilson, Antiretroviral Pregnancy Registry Steering Committee   +10 more
wiley   +1 more source

Costos Económicos Asociados al Uso de Tratamiento con Tremixclar® y Biktarkvy® en Personas que Viven con VIH Atendidos en la Clínica Especializada Condesa Iztapalapa [PDF]

La infección por VIH continúa representando un importante desafío de salud pública en México. Se trata de una enfermedad crónica transmisible con alta prevalencia que, debido a la naturaleza del virus y la falta de una cura definitiva, requiere ...
Rosas Becerril, Osmar Adrian
core   +1 more source